Eikon Therapeutics
Series D in 2025
Eikon Therapeutics is a biopharmaceutical company that uses proprietary live-cell imaging platforms to discover and develop therapeutics for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company applies super-resolution, single-molecule, and real-time molecular-resolution observations to study how compounds interact with individual proteins in living cells. By integrating biology, engineering, and chemistry, Eikon seeks to identify previously intractable targets, accelerate the drug-discovery process, and expand its clinical pipeline through platforms that reveal target biology and compound-protein interactions in their native cellular context.
Enechain is a solar energy solution company that specializes in creating an energy marketplace platform for trading energy products. The firm provides a price discovery function that helps visualize fair market prices, allowing users to understand the value of various energy offerings. In addition, Enechain's distribution function facilitates the conclusion of transactions and the distribution of products based on these fair prices, enabling efficient buying and selling within the energy sector. Through its innovative approach, Enechain aims to enhance the trading experience for users in the renewable energy market.
Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.
Tabby offers flexible payment solutions for online shopping. Based in the United Arab Emirates, it enables users to pay for purchases in deferred single payments or installments.
Pickle Robot Company
Series A in 2022
Founded in 2018 and based in Cambridge, Massachusetts, Pickle Robot Company develops collaborative robots for automating tasks along the e-commerce supply chain. Their first robot, Dill, works multiple shifts, communicates with human collaborators, and handles various parcel-related tasks such as loading/unloading trucks, palletizing/depalletizing, and preloading delivery vehicles.
Eikon Therapeutics
Series B in 2022
Eikon Therapeutics is a biopharmaceutical company that uses proprietary live-cell imaging platforms to discover and develop therapeutics for chronic and life-threatening diseases. Founded in 2019 and based in Hayward, California, the company applies super-resolution, single-molecule, and real-time molecular-resolution observations to study how compounds interact with individual proteins in living cells. By integrating biology, engineering, and chemistry, Eikon seeks to identify previously intractable targets, accelerate the drug-discovery process, and expand its clinical pipeline through platforms that reveal target biology and compound-protein interactions in their native cellular context.
Creapaper
Series B in 2021
Creapaper develops a grass-based raw material for paper production, primarily derived from grass fiber and dried hay, produced through a patented process to replace virgin wood fibers in paper and cardboard manufacturing. The company supplies the paper industry with this sustainable alternative and offers grass-based raw material, processed paper, and seed-embedded products that can be planted after use, including packaging concepts such as flower and herb boxes. Substituting grass for wood can reduce CO2 emissions in the manufacturing process by up to 75% and supports efforts to lower plastic pollution in the packaging and paper supply chain.
Paidy is a Japanese fintech company that offers a cardless real-time payment network. It enables consumers to buy online without a credit card or pre-registration, optimizing for mobile and instant-checkout. Paidy's platform uses proprietary technology to score creditworthiness, underwrite transactions, and guarantee payment to merchants.
Paidy is a Japanese fintech company that offers a cardless real-time payment network. It enables consumers to buy online without a credit card or pre-registration, optimizing for mobile and instant-checkout. Paidy's platform uses proprietary technology to score creditworthiness, underwrite transactions, and guarantee payment to merchants.
Aurigen Capital
Private Equity Round in 2007
Aurigen Capital Limited, established in 2007, is a Bermuda-based reinsurance company specializing in North American life insurance policies. It offers risk management solutions tailored to clients' needs, including pricing, underwriting, administration, and claims services. Aurigen's team of experienced professionals delivers creative yet rigorous solutions, backed by an efficient capital structure that enables competitive pricing for customers and potential returns for shareholders. As of 2017, Aurigen operates as a subsidiary of PartnerRe Ltd., following its acquisition in 2016.